Clinical Trials Directory

Trials / Completed

CompletedNCT06608368

A Clinical Study Assessing the Effects of a Marketed Dentifrice on Tooth Sensitivity While Undergoing Tooth Bleaching

A Randomized, Controlled Clinical Study Assessing the Effects of a Marketed Dentifrice Compared to a Regular Fluoride Dentifrice and a Positive Control Dentifrice on Tooth Sensitivity While Undergoing Tooth Bleaching

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
90 (actual)
Sponsor
HALEON · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to investigate the efficacy of a marketed dentifrice containing 5 percent (%) NovaMin (Calcium Sodium Phosphosilicate) to reduce tooth sensitivity during and post tooth bleaching compared to a marketed dentifrice containing 5% potassium nitrate (KNO3) and a marketed regular fluoride-containing dentifrice.

Detailed description

This is a randomized, examiner blind, single-center, controlled, three arm, parallel group, proof-of-principal study to evaluate tooth sensitivity during and following a course of at-home tooth bleaching in participants with and without clinically confirmed dentine hypersensitivity (DH). The study will recruit generally healthy participants who wish to undergo peroxide tooth bleaching. Sufficient participants will be screened to randomize approximately 90 participants to study treatment (approximately 30 per treatment group).

Conditions

Interventions

TypeNameDescription
DRUGTest Dentifrice (Sensodyne Repair and Protect Original Mint)Dentifrice containing 5% w/w NovaMin (Calcium Sodium Phosphosilicate) and 1040 ppm fluoride as sodium fluoride.
DRUGPositive Control Dentifrice (Sensodyne Fresh Mint)Dentifrice containing 5% w/w KNO3 and 1150 ppm fluoride as sodium fluoride.
DRUGReference Dentifrice (Crest Cavity Protection Regular)Dentifrice containing 1100 ppm fluoride as sodium fluoride.

Timeline

Start date
2024-10-07
Primary completion
2024-11-15
Completion
2024-11-15
First posted
2024-09-23
Last updated
2025-12-15
Results posted
2025-12-15

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06608368. Inclusion in this directory is not an endorsement.